The Role of Microbiota in Pancreatic Cancer and Precursor Lesions

Recruiting Observational Study
Pancreatic Cancer Microbiome
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
300 (estimated)
Sponsor
Herlev Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This is a prospective observational study aiming to investigate the microbiome in patients suspected of having pancreatic cancer. The purpose is to enhance diagnostic accuracy by developing screening protocols for high-risk individuals, identifying specific microbial biomarkers, and improving prognostic criteria to optimize treatment response. Participants will be asked to complete a questionnair…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients with a suspected lesion (solid/cystic) in the pancreas undergoing diagnostic or therapeutic endoscopic procedure * Age of 18 years or above * Signed informed consent form Exclusion Criteria: * Contraindications for endoscopic or surgical procedure, such as uncorrect…
Contacts

Bojan Kovacevic, ph.d., MD

0045 3868 6312

bojan.kovacevic@regionh.dk

CONTACT

Louise Maegaard, MSc, RN

90045 3868 9879

louise.maegaard@regionh.dk

CONTACT